Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2026-01-29 @ 5:43 AM
Study NCT ID:
NCT03873402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-12
First Post:
2019-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-29
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-11
First Submit QC Date:
None
Study First Post Date:
2019-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-10
Last Update Post Date:
2025-03-12
Last Update Post Date Type:
ACTUAL